Penumbra, Inc. (PEN): Innovating in Thrombectomy and Embolization With New FDA-Approved Technologies
Penumbra Insider Sold Shares Worth $3,559,176, According to a Recent SEC Filing
Penumbra(PEN.US) Officer Sells US$3.56 Million in Common Stock
$Penumbra(PEN.US)$ Officer Elsesser Adam sold 15,000 shares of common stock on Nov 20, 2024 at an average price of $237.28 for a total value of $3.56 million.Source: Announcement What is statement
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
Penumbra's Prospective Growth Amidst Market Dynamics Justifies Hold Rating
3 Reasons Growth Investors Will Love Penumbra (PEN)